ライフサイエンスコーパス: benign

1 healthy aging and is largely prognostically benign.

2 process atom economical and environmentally benign.

3 nctival tumors in children are nearly always benign.

4 s of uncertain significance, and 4 as likely benign.

5 As many as 74 were HCCs and 51 were benign.

6 nt individuals is typically asymptomatic and benign.

7 Avascular lesions were defined as benign.

8 is ubiquitous endogenous genotoxin creates a benign 1C unit that can sustain essential metabolism.

9 ore commonly unusual PC metastases (1.0%) or benign (3.1%).

10 n age, 54 years) with 144 renal lesions (111 benign, 33 malignant) measuring 1-4 cm underwent single-

11 Results A total of 210 lesions were benign, 43 were GS 6, and 90 were GS >/=7.

12 The tumor was benign (52%), premalignant (18%), or malignant (30%).

13 Overall, conjunctival tumors were benign (779 [97%]) or malignant (27 [3%]), including mel

14 All simple-appearing cysts were benign (95% CI: 99.6%, 100%).

15 s C) monitored by (1)H NMR spectroscopy show benign acetic acid as the only significant product.

16 regulated in ACC as compared with normal and benign adrenocortical tissues, which is a result of CpG

17 -economical, inexpensive and environmentally benign alternative to traditional transition-metal-catal

18 ts Of 55 testicular lesions, 43 (78.2%) were benign and 12 (21.8%) were malignant.

19 moscopy image datasets, which consist of 800 benign and 200 malignant melanoma cases.

20 The method is environmentally benign and atom-economical, and the only side product of

21 ied as pathogenic, likely pathogenic, likely benign and benign per the chance of causing the disease.

22 as pseudocysts and serous cystadenomas, are benign and can be monitored clinically, mucinous cysts,

23 ed to extract the viscoelastic properties of benign and cancerous cell lines (NIH 3T3 fibroblasts, NM

24 iants in ClinVar were reclassified to likely benign and excluded in testing yield analysis.

25 cinomas, exhibits only limited expression in benign and extraprostatic tissues, and thus represents a

26 However, the fact that both benign and harsh, as well as stable and fluctuating, env

27 gned by seven blinded independent readers to benign and malignant breast masses using OA/US versus US

28 US) to grayscale US alone in differentiating benign and malignant breast masses.

29 in tissue characterization, measurements of benign and malignant breast tumors were conducted (n = 6

30 The model accounted for benign and malignant causes of biliary obstruction and p

31 f oncogenic driver mutations, and similar in benign and malignant cells.

32 mm(2) as regrads the differentiation between benign and malignant cystic renal lesions.

33 ty of 93.0% were achieved in differentiating benign and malignant focal testicular lesions.

34 is likely to transform the practice of both benign and malignant hematology, but clinicians must car

35 US allows for a reliable differentiation of benign and malignant intratesticular lesions and can pot

36 Fewer than 2% of changes were between benign and malignant lymphoid conditions.

37 Benign and malignant mass upgrade and downgrade rates, p

38 ff ADC value for the differentiation between benign and malignant masses.

39 ying jaw fibromas, renal tumours and uterine benign and malignant neoplasms.

40 adults are predisposed to the development of benign and malignant nervous system tumors.

41 istics and patient attributes with regard to benign and malignant nodules in the NLST were applied to

42 s a valuable approach to distinguish between benign and malignant nodules.

43 tal Mesorectal Excision (taTME) registry for benign and malignant rectal pathology.

44 and material densities were compared between benign and malignant renal lesions by using the two-samp

45 oved specificity for differentiating between benign and malignant renal lesions compared with convent

46 as regards the differentiation between solid benign and malignant renal lesions.

47 ted imaging (DWI) for distinguishing between benign and malignant renal masses.

48 diagnostic method for distinguishing between benign and malignant renal masses.

49 in Na:Ca ratio in the apatite phase between benign and malignant specimens.

50 n and adults are prone to the development of benign and malignant tumors of the nervous system.

51 Features of benign and malignant tumors were compared.

52 bone, with no significant difference between benign and malignant.

53 We have used available databases of benign and pathogenic variants, alignment between divers

54 s and their modifications into proteins in a benign and precise manner are highly sought-after in pro

55 l observed after pancreaticoduodenectomy for benign and premalignant lesions.

56 Conjunctival tumors in children are usually benign and rarely malignant.

57 le TGFbeta signals are anti-proliferative in benign and well-differentiated pancreatic cells, TGFbeta

58 More than 50% of DCIS lesions are benign and will remain indolent, never progressing to in

59 bstructive CAD, a condition often considered benign and without guideline-recommended treatments.

60 ntracranial hypotension (IH) is an uncommon, benign, and usually self-limiting condition caused by lo

61 pulmonary structures become infiltrated with benign-appearing spindle and epithelioid cells (LAM cell

62 This environmentally benign approach furnishes a series of substituted indolo

63 duction of long-chain linear aldehydes under benign aqueous conditions.

64 rmful genes, facilitating a long-lasting and benign association.

65 ranulocytic asthma most likely represents a "benign" asthma phenotype, related to a good response to

66 Although most AAOCA subtypes are benign, autopsy studies report an associated risk of sud

67 f this study was to develop an environmental-benign bio-measure that could be used to purify dye-cont

68 ith a previous false-positive screening with benign biopsy.

69 Meningiomas are mostly benign brain tumours, with a potential for becoming atyp

70 body mass index (>25 vs 18.5-25), history of benign breast biopsy, and nulliparity or age at first bi

71 es from different pathogenetic pathways, and benign breast disease (BBD) predicts future non-TNBC.

72 placement therapy use, somatotype at age 18, benign breast disease, mammographic density, polygenic r

73 T3-high, ER+ breast cancer cells, but not in benign breast epithelial cells or in MYST3-low breast ca

74 io for differentiating between malignant and benign breast lesions, RTE findings were compared with h

75 ns with no targeted signal present in 67% of benign breast lesions.

76 procedure include a variety of malignant and benign breast lesions.

77 the differential diagnosis of malignant and benign breast lesions.

78 in the differentiation between malignant and benign breast masses, but it should be used in conjuncti

79 invasive differentiation of malignant versus benign breast tumors with PET.

80 er, TGF-beta induced apoptosis in normal and benign but not in carcinoma cultures.

81 The prognosis was initially thought to be benign, but subsequent studies have demonstrated that bo

82 Herein, a highly efficient, environmentally benign catalytic B-C bond formation method is presented

83 Kimura disease is an uncommon, benign, chronic, idiopathic disease that is seen mainly

84 One patient developed a benign clonal dominance that could not be attributed to

85 opportunistic pathogen, typically found as a benign commensal yeast living on skin and mucosa, but po

86 in three of the four patients is remarkably benign compared to other hypomyelinating disorders, with

87 The most active group, however, had a more benign composition of plaques, with fewer mixed plaques

88 excision is the treatment of choice for this benign condition, which requires a follow-up only in cer

89 atus presented for gynecologic surgery for a benign condition.

90 gically confirmed PCa patients from prostate benign conditions (BCs) patients with prostatitis or pro

91 Knowledge of benign conditions that might mimic a mediastinal vascula

92 practical, inexpensive, and environmentally benign conditions.

93 ients, 747 (86%) had cancer and 91 (11%) had benign conditions/pancreatitis.

94 basal diameter and thickness, compared with benign counterparts.

95 d metabolic derangements compared with their benign counterparts.

96 However, treatment of patients with benign course may not be needed; therefore, there is a n

97 cent of other LMNA mutations but with a more benign course.

98 e majority of patients, HCM has a relatively benign course.

99 n of Cr(VI) to less soluble, environmentally benign Cr(III).

100 groups as malignant cystic, malignant solid, benign cystic and benign solid.

101 guidelines would have reduced the number of benign cysts sent for surgical evaluation.

102 P < .0001, both trends) and 82 (89.1%) fewer benign cysts would have gone directly to surgical evalua

103 ons (carcinoma and lymphoma; 27/76, 36%) and benign dacryoadenitis (15%) were significantly different

104 reaction aluminum anodes and environmentally benign deep-eutectic-solvent anolytes reveals great pote

105 ore, continued interrogation of oncogenes in benign developmental disorders could provide insight int

106 Current selection factors for MIDP were benign disease (odds ratio: OR: 1.56, CI: 1.10-2.21) and

107 Current selection factors for ODP or MIDP (benign disease, tumor size, and BMI) do not mitigate the

108 hyroidectomy, 47% had thyroid cancer and 53% benign disease.

109 The benign dissolution advantageously maintains the morpholo

110 while relying on FeCl3 as an environmentally benign, earth-abundant metal catalyst.

111 crease in on-current magnitude, signalling a benign effect of tensile strain on the carrier transport

112 However, fetuin-A inverted these benign effects of RSFC from an anti- to a proinflammator

113 between nsSNVs with dominant, recessive, and benign effects.

114 Early benign electroencephalography heralded good outcome in 8

115 iovascular system ranging from transient and benign electrographic changes to myocardial injury, card

116 We propose that the benign environment in captivity may decrease the intensi

117 Children with benign epilepsy with centrotemporal spikes (BECTS) have

118 Whereas benign epithelium in prostates with and without tumor we

119 In 24 patients (3.1%), lesions had a benign etiology.

120 Although neonatal jaundice is mostly benign, excessively high levels of serum bilirubin in a

121 ophy or increased tendon reflexes suggests a benign fasciculation syndrome, even when of sudden onset

122 amyotrophic lateral sclerosis (ALS), and in benign fasciculation syndromes.

123 , 58% were not seen or were characterized as benign findings at second-look analysis.

124 Benign outcome was determined by benign findings at surgery, a decrease in size or resolu

125 ategory 2 findings (ie, stable postoperative benign findings).

126 Differentiation of benign from malignant counterparts.

127 stic curve (AUROC) for QSWP to differentiate benign from malignant lesions was 0.913, with a sensitiv

128 and visual interpretation for discriminating benign from malignant SPNs, especially by texture featur

129 yclic molecules to fabricate environmentally benign functional nanomaterials.

130 Autophagy is required for benign hepatic tumors to progress into malignant hepatoc

131 nt stages, 30 from age-matched patients with benign hepatobiliary disorders (BHD) and 20 from age-mat

132 more difficult, because of the abundance of benign heterozygous variants that act as massive backgro

133 al that papillary craniopharyngioma (PCP), a benign human pituitary tumour harbouring BRAF p.V600E al

134 n is restricted to basal epithelial cells in benign human prostate but is upregulated in luminal epit

135 (BCs) patients with prostatitis or prostate benign hyperplasia (BPH).

136 dermoscopy, MAC were correctly classified as benign in 13 of 16 cases (81%) and MEL were classified a

137 Most causes of LBP are musculoskeletal and benign in their clinical course.

138 This method is environmentally benign, inexpensive, and scalable to produce optical com

139 that warrant surgical removal from 'indolent/benign' IPMNs that can be observed.

140 nteers and 9 patients with iris melanomas or benign iris lesions, including freckles, nevi, and an ir

141 raphy (OCTA) in malignant iris melanomas and benign iris lesions.

142 s melanomas (34.5%+/-9.8%, P < 0.05) than in benign iris nevi (8.0%+/-1.4%) or normal irides (8.0%+/-

143 gh ADC values, while meningioma was the only benign lesion with restricted diffusion.

144 These models recapitulate early benign lesions and suggest that a latency period exists

145 al studies report consistent loss of PAX2 in benign lesions as well as serous tumors.

146 melanomas biopsied and reduce the number of benign lesions biopsied, thereby improving patient outco

147 rgery, and 30.6% (91 of 297) of surgeries of benign lesions could have been avoided.

148 lens and proper protection for patients with benign lesions during GKRS.

149 The mean ADC value of benign lesions was 1.948+/-0.459x10(-3) mm(2)/s, while t

150 cer cases and 51 controls with biopsy-proven benign lesions, matched by age and year-of-MRI.

151 lesions and 2.79+/-2.16 (range 0.6-8.7) for benign lesions, respectively (p<0.05).

152 s found in 21 (88%) LM or LMM and in 3 (77%) benign lesions.

153 malignant lesions are more frequent than the benign lesions.

154 d 200 nonhematopoietic neoplasms, with 4,390 benign lesions.

155 of NF1 is the plexiform neurofibroma (PN), a benign, likely congenital tumor that arises from bi-alle

156 hed human hepatocellular carcinoma (HCC) and benign liver tissue to identify miRNA target sites trans

157 icular nodular hyperplasia (FNH) is a common benign liver tumor for which conservative management is

158 D & AIMS: Hepatocellular adenomas (HCAs) are benign liver tumors that can be assigned to molecular su

159 er for differentiating between malignant and benign LNs.

160 tosis that develops as a slowly progressive, benign, localized or generalized enlargement of keratini

161 for SHC in an economical and environmentally benign manner.

162 However, benign may be a misnomer because BECTS is linked to cogn

163 e, we studied the reactions of malignant and benign melanocyte lines to cytotoxic CD8(+) T cells (CTL

164 y 33% of melanomas are derived directly from benign, melanocytic nevi.

165 Benign melanotic macules (MAC) are the most frequent cau

166 iptomic and epigenomic analyses, we compared benign meningiomas to atypical ones.

167 neoplasms, including 1026 malignancies, 233 benign meningiomas, and 1856 nonmelanoma skin cancers.

168 A mild and environmentally benign method for the deuteration of alkyl iodides via r

169 rt a general, efficient, and environmentally benign method for the one-pot cascade synthesis of quina

170 chemicals, and more importantly demonstrates benign methods for valorization of polymeric lignin that

171 ce of an active multiple myeloma clone and a benign MGUS clone, and thus provides a unique model to a

172 ty for a more economical and environmentally benign mining process, as well as the design of more eff

173 fibroblast cell in children has 1035 mostly benign mosaic SNVs.

174 =30)] were classified as malignant (n=36) or benign (n=43).

175 The image of thiacloprid as a relatively benign neonicotinoid should now be questioned.

176 istribution of outcomes (nonneoplastic cyst, benign neoplasm, malignant neoplasm) was compared in eac

177 475 (83.3%) nonneoplastic cysts, 77 (13.5%) benign neoplasms, and 18 (3.2%) malignant neoplasms.

178 Paragangliomas are benign neuroendocrine tumors derived from the glomus cel

179 rature formate fuel cell that operates under benign neutral pH conditions.

180 ic keratoses; and malignant melanomas versus benign nevi.

181 t data were available for 4431 nodules (4315 benign nodules and 116 malignant nodules) from the NLST

182 ltiple thresholds were tested to distinguish benign nodules from malignant nodules.

183 optimal discrimination between malignant and benign nodules.

184 istors were fabricated using environmentally benign, nonchlorinated solvents, with the CPDS and IDSe

185 1993, and December 31, 2012, and underwent a benign, nongravid hysterectomy between January 1, 1996,

186 n between the pathological condition and the benign one is very challenging in the surgical setting;

187 ted in atypical tumours that progressed from benign ones.

188 ges 3-25 years) with residual or progressive benign or low-grade brain tumors at a single center betw

189 ng patients with residual and/or progressive benign or low-grade brain tumors requiring radiotherapy

190 ng patients with residual and/or progressive benign or low-grade brain tumors treated with SCRT and C

191 Long-term QOL outcomes after PD for benign or malignant disease are largely undocumented.

192 ched for pathology-proven testicular tumors (benign or malignant germ cell or stromal tumors).

193 lesions were diagnosed in 54 individuals as benign or malignant neoplasms.

194 curacy in characterizing sinonasal masses as benign or malignant.

195 Using 14,819 benign or pathogenic missense variants from the ClinVar

196 Hepatic steatosis may be benign or progress to hepatocyte injury and the initiati

197 ty, epileptiform features, and prespecified "benign" or "highly malignant" patterns based on the Amer

198 ied on screening, with 32 having incidental, benign, or normal findings, resulting in a false-positiv

199 cancer organoids, they had no effect on the benign organoids.

200 Benign outcome was determined by benign findings at surg

201 ysts with an adequate reference standard for benign outcome.

202 ions, with no targeted signal seen in 78% of benign ovarian lesions.

203 ays, primary hyperparathyroidism is due to a benign overgrowth of parathyroid tissue either as a sing

204 also with the aim to create environmentally benign oxidants.

205 a recyclable medium for the environmentally benign oxidation of conjugated alkenes with H2O2.

206 cancer from healthy donors and patients with benign pancreatic disease.

207 ined TGFBR1-dependent ERK phosphorylation in benign pancreatic duct cells.

208 chemically induced mouse cSCCs, compared to benign papillomas.

209 634 patients with rectal cancer and 86 with benign pathology.

210 Familial benign pemphigus, or Hailey-Hailey disease (HHD), is a r

211 ogenic, likely pathogenic, likely benign and benign per the chance of causing the disease.

212 Intraneural perineuriomas are benign peripheral nerve sheath tumors that cause progres

213 Neurofibromas are benign peripheral nerve tumors driven by NF1 loss in Sch

214 d as LM or LM melanoma (LMM) and 39 (62%) as benign pigmented lesions.

215 ple of a manganese-catalyzed environmentally benign, practical three-component aminomethylation of ac

216 ctal cancers, as compared with corresponding benign precursor adenomas.

217 ned the effects of the SELECT supplements on benign (primary), premalignant ( RWPE-1) and malignant (

218 CS2 and COS pollutants into environmentally benign products is important for both fundamental cataly

219 transporter and intracellular zinc levels in benign prostate cells, PCa xenografts and fresh prostate

220 n that suppresses pro-invasive properties in benign prostate epithelium.

221 relative to both normal prostate tissue and benign prostate hyperplasia (BPH).

222 Our study evaluates SUVs in benign prostate tissue and malignant, intraprostatic tum

223 ine, glycine, and choline tissue levels from benign prostate tissue to localized prostate cancer and

224 placed on each patient's dominant tumor and benign prostate tissue.

225 Here, we use a ranking score and benign prostate transcriptomes to identify a non-coding

226 Chronic prostatitis (CPr) and benign prostatic hyperplasia (BPH) are complex inflammat

227 The etiology of benign prostatic hyperplasia (BPH) is multifactorial, an

228 umes of interest (VOIs) for prostate tumors, benign prostatic hyperplasia (BPH) nodules, prostatitis,

229 lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH), the etiology of whic

230 Urinary complications resulting from benign prostatic hyperplasia and bladder outlet obstruct

231 tissues is significantly higher than that in benign prostatic hyperplasia tissues, and PRMT5 expressi

232 itiation, and to develop novel therapies for benign prostatic hyperplasia.

233 orts to distinguish pathogenic variants from benign rare variants have leveraged the genetic code to

234 top 5 diagnoses included nevus (492 [61%]), benign reactive lymphoid hyperplasia (BRLH) (38 [5%]), n

235 Comparison of benign reactive lymphoid hyperplasia vs lymphoma reveale

236 ponent that represents a second neoplasm or (benign) reactive process.

237 troy lung parenchyma and by the formation of benign renal neoplasms called angiolipomas.

238 f thyroid cancers, compared with none of the benign samples (P = 0.0007).

239 tational profiles derived from malignant and benign samples.

240 affected patients are predisposed to develop benign Schwann cell (SC) tumours called neurofibromas.

241 on use cases: keratinocyte carcinomas versus benign seborrheic keratoses; and malignant melanomas ver

242 in metastatic tumours versus normal skin or benign skin lesions.

243 The majority of pediatric gliomas present as benign, slow-growing lesions classified as grade I or II

244 t cystic, malignant solid, benign cystic and benign solid.

245 An environmentally benign solvent combination not only adds to the attracti

246 ing with the immunopeptidome of a variety of benign sources has unveiled a multitude of ovarian cance

247 ss cariogenic/pathogenic species and promote benign species.

248 hese models to classify prostate cancer from benign specimens with nearly 90% accuracy per patient.

249 TPI) can differentiate between malignant and benign SPNs in patients from granuloma-endemic regions.

250 Indeed, a distress response to benign stimuli that "resemble" aspects of the trauma is

251 atteries: The development of environmentally benign sustainable energy storage systems is eagerly awa

252 LCA revealed a set of benign, symptomatic, and severe atopy phenotypes.

253 Testicular adrenal rest tumours (TARTs) are benign testicular masses that are found in inadequately

254 th-abundant elements and are environmentally benign, thus representing a promising choice for sustain

255 erexpressed in thyroid cancers compared with benign thyroid tissues (P < 0.0001).

256 and PET alone for distinguishing tumors from benign tissue (AUCs of 87%, 81%, and 83%, respectively,

257 ion was performed to distinguish tumors from benign tissue (BPH, prostatitis, or healthy tissue) and

258 umors from other tissue (low-grade tumors or benign tissue).

259 gh specificity to distinguish malignant from benign tissue, both impeding diagnosis of early and meta

260 ly informative in distinguishing cancer from benign tissue.

261 ays, we documented a positive correlation in benign tissues of IGF2 levels with phospho-ERK and phosp

262 ors, high-grade and low-grade carcinomas and benign tissues.

263 gnant prostate as compared to their adjacent benign tissues.

264 sing a spectrum of diseases ranging from the benign to the life threatening, occurs during physiologi

265 adoxical pupillary constriction to darkness, benign tonic upgaze of infancy, congenital fibrosis synd

266 boundaries may be beneficial, detrimental or benign towards device performance.

267 Ganglioneuroma (GN) is a rare benign tumor arising from the neural crest cells.

268 for ODP were PDAC (OR: 0.45, CI: 0.31-0.64), benign tumor size >5 centimeters (OR: 0.40, CI: 0.23-0.6

269 The mean age at detection was 11 years for benign tumors and 14 years for malignant tumors (P = .00

270 in malignant tumors and the lowest uptake in benign tumors and normal mammary tissue.

271 l as the differentiation of malignant versus benign tumors based on absolute labeling uptake.

272 Hepatocellular adenomas (HCAs) are rare benign tumors divided into three main subgroups defined

273 and familial schwannomatosis, with adulthood benign tumors involving cranial and peripheral nerves.

274 Infantile hemangiomas are the most common benign tumors of infancy and childhood with a reported i

275 Aldosterone-producing adenomas (APAs) are benign tumors of the adrenal gland that constitutively p

276 Infantile hemangiomas are benign tumors of vascular endothelial cells (ECs), chara

277 These benign tumors represent clonal hyperproliferation of mel

278 conjunctival tumors in children by comparing benign tumors with their malignant counterparts.

279 specific (and may, in fact, also be found in benign tumors).

280 in human neuroblastoma tumors compared with benign tumors, with loss correlating with decreased surv

281 rodevelopmental deficits and the presence of benign tumors.

282 The pleomorphic adenoma was the most common benign tumour and was also the second most common tumour

283 enetic disease causing multisystem growth of benign tumours and other hamartomatous lesions, which le

284 , infantile haemangiomas are the most common benign tumours of infancy, arising in the first few week

285 e categorization of breast lesions as either benign usual ductal hyperplasia (UDH) or malignant ducta

286 fic protein maps and compared our results to benign variants appearing in control databases.

287 ccurately distinguishes known pathogenic and benign variants in synonymous (AUC = 0.88) and intronic

288 between deleterious variants in patients and benign variants in unaffected siblings.

289 nic (AUC = 0.83) public datasets, dismissing benign variants with exceptionally high specificity.

290 patient, to distinguish disease-causing from benign variants.

291 s techniques to differentiate non-invasively benign versus malignant breast lesions.

292 These biomarkers were utilized to classify benign versus malignant lesions with leave-one-patient-o

293 fferences in QOL or functional scores in the benign versus malignant subgroups.

294 .002) for ADC (0.921) than for K (0.902) for benign versus malignant tissue but was similar for GS </

295 ADC and K showed significant differences for benign versus tumor tissues, GS </= 3 + 3 versus GS >/=

296 conjunctival tumors in all ages and compare benign vs malignant counterparts.

297 ZIKV infection is usually benign, when symptomatic, but in countries at risk of ZI

298 riminate premalignant/malignant lesions from benign with an accuracy of 97% (95% CI, 89% to 99%) in t

299 ain (MR766 Uganda: ZIKV(U)) considered to be benign with regards to effects on fetal development.

300 cherichia coli (ExPEC) strains are typically benign within the mammalian gut but can disperse to extr